Table 1.
Evaluation of costs and benefits of initiatives
| Robust evidencea from evaluation on: | ||
|---|---|---|
| Initiative | Health or care outcomes | NHS or social care costs |
| Care closer to home demonstration sites | ✗ | Limited |
| Improving Access to Psychological Therapies | ✓b | ✓b |
| Individual budgets | ✓ | ✓ |
| Information prescription | Limited | Very limited |
| New types of workers pilots | Very limited | ✗ |
| NHS LifeCheck | ✗ | ✗ |
| Partnerships for older people | Very limited | Limited |
| Self-referral to physiotherapy | ✗ | ✗ |
| Social enterprise pathfinders | ✗ | Limited |
| Whole System long-term condition demonstration sites | (✓) | (✓) |
a
Robust evidence = comparison between those receiving the initiative and a concurrent, comparable, control group. Data about health or social care outcomes based on reliable empirical data collected directly from patients/clients; data about costs based on economic analysis of directly collected data about resource utilisation and costs.
b
Control areasmay have important differences fromintervention areas.
✓ = robust evidence available. ✗ = no robust evidence. ( ) Planned, but results not yet available.